Rural-urban differences and association of sexual autonomy with uptake of breast and cervical cancer screening services among women of reproductive age in Ghana - Takeaways - MDSpire

Rural-urban differences and association of sexual autonomy with uptake of breast and cervical cancer screening services among women of reproductive age in Ghana

  • By

  • Benjamin Ansah Dortey

  • Stanley Kofi Alor

  • Emmanuel Anongeba Anaba

  • Charlotte Abra Esime Ofori

  • Yula Salifu

  • Henry Ekow Yanney

  • James Akazili

  • July 2, 2026

  • 0 min

Share

  • 1

    Breast and cervical cancers are leading causes of morbidity and mortality among women in sub-Saharan Africa, with low screening uptake in Ghana.

  • 2

    The study analyzed data from 8,044 women aged 15–49 years in the 2022 Ghana Demographic and Health Survey to assess screening uptake.

  • 3

    Women with sexual autonomy were more likely to participate in breast cancer and cervical cancer screening, with stronger associations in urban areas.

  • 4

    Sexual autonomy significantly predicted cervical cancer screening only in urban settings, while no significant association was found in rural areas.

  • 5

    The findings highlight rural-urban disparities in women's empowerment and access to cancer screening services in Ghana.

Original Source(s)

Rural-urban differences and association of sexual autonomy with uptake of breast and cervical cancer screening services among women of reproductive age in Ghana

  • by Benjamin Ansah Dortey, Stanley Kofi Alor, Emmanuel Anongeba Anaba, Charlotte Abra Esime Ofori, Yula Salifu, Henry Ekow Yanney, James Akazili

  • July 2, 2026

Related Content

Identification of potential vinorelbine-associated prognostic genes in breast cancer through integrative bioinformatics and experimental validation

Clinical and prognostic implications of pituitary tumor-transforming gene 1 in solid tumors

ESMO Breast Cancer 2026 Highlights: TRAK-ER

Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH discuss results from the TRAK-ER trial, which were presented at the 2026 ESMO Breast Cancer Congress.

  • June 26, 2026

  • 1 min